Atorvastatin Rapidly Reduces Hepatitis B Viral Load in Combination with Tenofovir: A Prospective Clinical Trial

METHOD: In this single-blind clinical trial, 40 patients with active chronic hepatitis B were randomly allocated to treatment or control groups. The treatment group received the standard treatment for chronic HBV (300 mg tenofovir twice a day) along with 40 mg/day atorvastatin for 12 months, while t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharehbeglou, M., Yazdani, S., White, K., Haeri, M. R., Masoumzadeh, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303483/
https://www.ncbi.nlm.nih.gov/pubmed/35873362
http://dx.doi.org/10.1155/2022/3443813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303483/
https://www.ncbi.nlm.nih.gov/pubmed/35873362
http://dx.doi.org/10.1155/2022/3443813

Ejemplares similares